Rondo Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 02, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $67,000,000
Company Info
- Company Description
- Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
- Market
- Immunotherapy for solid tumors
- Location
- San Francisco, California, USA
- Coinvestors
- Canaan Partners, Johnson & Johnson Development Corporation (JJDC), Novo A/S, Red Tree Venture Capital, SV Health Investors